Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karyn Foster

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Cell Physiology|March 9, 2007
S-acylation regulates Kv1.5 channel surface expressionLian Zhang, Karyn Foster, Qiuju Li, et al.
BMJ Supportive & Palliative Care|November 15, 2022
Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trialsTaylan Gurgenci, Janet Hardy, Rebecca Olson, et al.
BMJ Supportive & Palliative Care|January 20, 2022
Oral water-soluble contrast for malignant bowel obstruction: open label pilot studyWan Fadzrul Izuan Bin Wan Bahrum, Janet Hardy, Karyn Foster, et al.
The Cochrane Database of Systematic Reviews|January 23, 2023
Corticosteroids for the management of cancer-related fatigue in adults with advanced cancerAmy Sandford, Alison Haywood, Kirsty Rickett, et al.
Palliative Medicine|December 24, 2024
Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility studyKaryn Foster, Geoff Mitchell, Evan Richard, et al.
BMJ Supportive & Palliative Care|December 18, 2025
Genomic variation in symptom expression in castrate-resistant prostate cancerJanet Hardy, Ristan Greer, Karyn Foster, et al.
Trials|May 30, 2024
Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Trials|May 1, 2024
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Cell Physiology|March 9, 2007
S-acylation regulates Kv1.5 channel surface expressionLian Zhang, Karyn Foster, Qiuju Li, et al.
BMJ Supportive & Palliative Care|November 15, 2022
Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trialsTaylan Gurgenci, Janet Hardy, Rebecca Olson, et al.
BMJ Supportive & Palliative Care|January 20, 2022
Oral water-soluble contrast for malignant bowel obstruction: open label pilot studyWan Fadzrul Izuan Bin Wan Bahrum, Janet Hardy, Karyn Foster, et al.
The Cochrane Database of Systematic Reviews|January 23, 2023
Corticosteroids for the management of cancer-related fatigue in adults with advanced cancerAmy Sandford, Alison Haywood, Kirsty Rickett, et al.
Palliative Medicine|December 24, 2024
Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility studyKaryn Foster, Geoff Mitchell, Evan Richard, et al.
BMJ Supportive & Palliative Care|December 18, 2025
Genomic variation in symptom expression in castrate-resistant prostate cancerJanet Hardy, Ristan Greer, Karyn Foster, et al.
Trials|May 30, 2024
Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Trials|May 1, 2024
Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trialTaylan Gurgenci, Janet Hardy, Georgie Huggett, et al.
Pageof 1